| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |